Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Boston Scientific buys remainder of Cameron Health for $150mm up front, up to $1.2bn in earn-outs

Executive Summary

Boston Scientific Corp. has acquired privately held Cameron Health Inc. (implantable defibrillator) for $150mm up front and another $1.2bn in earn-outs, of which $150mm is payable upon FDA approval of the S-ICD defibrillator system, and another $1.05bn for revenue-based milestones for the six-year period following approval.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Earnout
    • Partial Acquisition
    • Payment Includes Cash

Related Companies